de Northern Trust AbbVie ABBV Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 5173 M | Vender |
20,558,447
-652,935
| -3% | -USD 140 M | 0.6% | 25 |
|
|
2026
Q1 | USD 4613 M | Vender |
21,211,382
-522,541
| -2% | -USD 116 M | 0.61% | 20 |
|
|
2025
Q4 | USD 4966 M | Vender |
21,733,923
-312,304
| -1% | -USD 71.1 M | 0.63% | 19 |
|
|
2025
Q3 | USD 5105 M | Comprar |
22,046,227
+32,853
| +0.1% | +USD 6.69 M | 0.65% | 19 |
|
|
2025
Q2 | USD 4086 M | Vender |
22,013,374
-546
| -0% | -USD 101 k | 0.56% | 25 |
|
|
2025
Q1 | USD 4612 M | Comprar |
22,013,920
+189,294
| +0.9% | +USD 36.8 M | 0.68% | 21 |
|
|
2024
Q4 | USD 3878 M | Comprar |
21,824,626
+2,299,645
| +12% | +USD 423 M | 0.55% | 25 |
|
|
2024
Q3 | USD 3856 M | Vender |
19,524,981
-759,111
| -4% | -USD 142 M | 0.63% | 22 |
|
|
2024
Q2 | USD 3479 M | Comprar |
20,284,092
+33,832
| +0.2% | +USD 5.6 M | 0.59% | 23 |
|
|
2024
Q1 | USD 3688 M | Vender |
20,250,260
-685,853
| -3% | -USD 118 M | 0.64% | 22 |
|
|
2023
Q4 | USD 3244 M | Vender |
20,936,113
-1,000,166
| -5% | -USD 146 M | 0.59% | 24 |
|
|
2023
Q3 | USD 3270 M | Comprar |
21,936,279
+491,391
| +2% | +USD 72.1 M | 0.63% | 23 |
|
|
2023
Q2 | USD 2889 M | Vender |
21,444,888
-780,116
| -4% | -USD 114 M | 0.56% | 26 |
|
|
2023
Q1 | USD 3542 M | Comprar |
22,225,004
+268,579
| +1% | +USD 41.1 M | 0.7% | 21 |
|
|
2022
Q4 | USD 3548 M | Comprar |
21,956,425
+101,629
| +0.5% | +USD 15.6 M | 0.74% | 19 |
|
|
2022
Q3 | USD 2933 M | Vender |
21,854,796
-319,948
| -1% | -USD 45.9 M | 0.67% | 21 |
|
|
2022
Q2 | USD 3396 M | Vender |
22,174,744
-456,417
| -2% | -USD 69.7 M | 0.73% | 22 |
|
|
2022
Q1 | USD 3669 M | Vender |
22,631,161
-186,365
| -0.8% | -USD 27.1 M | 0.65% | 21 |
|
|
2021
Q4 | USD 3089 M | Comprar |
22,817,526
+1,806
| +0% | +USD 213 k | 0.51% | 30 |
|
|
2021
Q3 | USD 2461 M | Comprar |
22,815,720
+161,083
| +0.7% | +USD 18.4 M | 0.44% | 41 |
|
|
2021
Q2 | USD 2552 M | Vender |
22,654,637
-1,072,864
| -5% | -USD 121 M | 0.45% | 35 |
|
|
2021
Q1 | USD 2568 M | Vender |
23,727,501
-185,978
| -0.8% | -USD 19.9 M | 0.48% | 32 |
|
|
2020
Q4 | USD 2562 M | Vender |
23,913,479
-449,713
| -2% | -USD 43.2 M | 0.5% | 31 |
|
|
2020
Q3 | USD 2134 M | Comprar |
24,363,192
+210,056
| +0.9% | +USD 19.8 M | 0.47% | 39 |
|
|
2020
Q2 | USD 2371 M | Comprar |
24,153,136
+3,808,707
| +19% | +USD 335 M | 0.56% | 29 |
|
|
2020
Q1 | USD 1550 M | Comprar |
20,344,429
+895,939
| +5% | +USD 76.3 M | 0.45% | 45 |
|
|
2019
Q4 | USD 1722 M | Vender |
19,448,490
-182,144
| -0.9% | -USD 15.1 M | 0.39% | 49 |
|
|
2019
Q3 | USD 1486 M | Vender |
19,630,634
-525,315
| -3% | -USD 36 M | 0.36% | 51 |
|
|
2019
Q2 | USD 1466 M | Vender |
20,155,949
-56,135
| -0.3% | -USD 4.41 M | 0.35% | 53 |
|
|
2019
Q1 | USD 1629 M | Vender |
20,212,084
-817,581
| -4% | -USD 66.9 M | 0.4% | 47 |
|
|
2018
Q4 | USD 1939 M | Comprar |
21,029,665
+227,408
| +1% | +USD 20 M | 0.54% | 32 |
|
|
2018
Q3 | USD 1967 M | Vender |
20,802,257
-425,114
| -2% | -USD 40.3 M | 0.48% | 33 |
|
|
2018
Q2 | USD 1967 M | Vender |
21,227,371
-425,398
| -2% | -USD 41.5 M | 0.5% | 33 |
|
|
2018
Q1 | USD 2049 M | Vender |
21,652,769
-449,836
| -2% | -USD 49.4 M | 0.53% | 31 |
|
|
2017
Q4 | USD 2138 M | Vender |
22,102,605
-220,261
| -1% | -USD 20.8 M | 0.54% | 31 |
|
|
2017
Q3 | USD 1984 M | Comprar |
22,322,866
+1,219,921
| +6% | +USD 92.9 M | 0.52% | 36 |
|
|
2017
Q2 | USD 1530 M | Vender |
21,102,945
-219,511
| -1% | -USD 14.8 M | 0.43% | 42 |
|
|
2017
Q1 | USD 1389 M | Vender |
21,322,456
-133,177
| -0.6% | -USD 8.37 M | 0.4% | 43 |
|
|
2016
Q4 | USD 1344 M | Vender |
21,455,633
-220,741
| -1% | -USD 13.5 M | 0.41% | 43 |
|
|
2016
Q3 | USD 1367 M | Vender |
21,676,374
-303,888
| -1% | -USD 19.7 M | 0.43% | 45 |
|
|
2016
Q2 | USD 1361 M | Vender |
21,980,262
-47,319
| -0.2% | -USD 2.88 M | 0.44% | 47 |
|
|
2016
Q1 | USD 1257 M | Vender |
22,027,581
-292,030
| -1% | -USD 16.3 M | 0.42% | 48 |
|
|
2015
Q4 | USD 1322 M | Vender |
22,319,611
-1,497,409
| -6% | -USD 86.2 M | 0.44% | 46 |
|
|
2015
Q3 | USD 1296 M | Vender |
23,817,020
-1,766,035
| -7% | -USD 115 M | 0.43% | 46 |
|
|
2015
Q2 | USD 1719 M | Comprar |
25,583,055
+1,335,123
| +6% | +USD 87.2 M | 0.52% | 33 |
|
|
2015
Q1 | USD 1419 M | Vender |
24,247,932
-106,888
| -0.4% | -USD 6.46 M | 0.43% | 47 |
|
|
2014
Q4 | USD 1594 M | Vender |
24,354,820
-112,783
| -0.5% | -USD 7.11 M | 0.48% | 38 |
|
|
2014
Q3 | USD 1413 M | Vender |
24,467,603
-977,586
| -4% | -USD 54.3 M | 0.44% | 39 |
|
|
2014
Q2 | USD 1436 M | Vender |
25,445,189
-152,622
| -0.6% | -USD 8.01 M | 0.45% | 41 |
|
|
2014
Q1 | USD 1316 M | Vender |
25,597,811
-256,430
| -1% | -USD 13 M | 0.41% | 45 |
|
|
2013
Q4 | USD 1365 M | Comprar |
25,854,241
+510,071
| +2% | +USD 25.1 M | 0.44% | 42 |
|
|
2013
Q3 | USD 1134 M | Vender |
25,344,170
-961,821
| -4% | -USD 42.6 M | 0.4% | 46 |
|
|
2013
Q2 | USD 1087 M | Comprar |
+26,305,991
| Nuevas | +USD 1151 M | 0.39% | 46 |
|
Otros fondos que tienen ABBV en su cartera
Posición de Northern Trust en ABBV: resumen de T2 2026
Northern Trust redujo su participación en AbbVie (ABBV) en 3.1% durante T2 2026, al vender acciones por un valor estimado de USD 140 M, y conservó 20,558,447 acciones valuadas en USD 5173 M. La posición representa 0.6% de la cartera y ocupa el puesto #25.
Northern Trust reportó por primera vez una posición en ABBV en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 4,253 fondos que sigue Wall St. Rank mantienen una posición en ABBV.
- Al cierre de T2 2026, Northern Trust tenía 20,558,447 acciones de AbbVie con un valor de USD 5173 M.
- Northern Trust vendió 652,935 acciones de AbbVie en T2 2026, por un valor estimado de USD 140 M.
- AbbVie representó 0.6% de la cartera de Northern Trust en T2 2026 y fue su posición número 25.
- Northern Trust reportó por primera vez una posición en AbbVie en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 4,253 fondos que sigue Wall St. Rank tenían AbbVie en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.